Some governments are willing to consider reform and the WACD wants to further support this ongoing work with the Model Drug Law, which provides concrete templates that countries can adapt to reform their drug laws: legal provisions and how they relate to international legal obligations as well as useful commentary that explains different options and reasons for choosing the proposed legal solution ( Global Commission on Drug Policy)
Bibliography: Production and Supply
Europe’s legal cannabis market set to become worth more than €115 billion
A new report “European Cannabis Report” from industry advisors, Prohibition Partners, suggests that Europe will become the largest legal cannabis market in the world once all countries have introduced legislation and regulation during the next 10 years (Manufacturing Chemist)
World Drug Report 2018
Opioid crisis, prescription drug abuse expands; cocaine and opium hit record highs Index (UNODC)
Crypto-Market Enforcement – New Strategy and Tactics
Law enforcement has gained deeper knowledge of the cryptomarket environment (GDPO)
Afghan Narcotics: 2000-2018
From Control and Elimination Efforts to a Drug Economy and Bombings Labs (CSIS)
Precursor chemical licensing
Licence and registration application information for companies that deal in precursor chemicals (Home Office)
Methamphetamine contamination in residential properties: Exposures, risk levels, and interpretation of standards
There is currently no evidence that methamphetamine levels typically resulting from third-hand exposure to smoking residues on household surfaces can elicit an adverse health effect (Chief Science Advisor, New Zealand)
EMCDDA releases its first analysis on monitoring drug-related homicide in Europe
An EMCDDA paper providing an overview of the information available on drug-related homicide (DRH) in Europe
Afghanistan opium survey 2017 (PDF)
Challenges to sustainable development, peace and security (UNODC)
Fentanyl: preparing for a future threat
Incident planning for potent opioids arriving into the illicit drug market (Public Health England)
Darknet markets ecosystem – Lifetimes and reasons for closure of over 100 global darknet markets offering drugs, sorted by date
It is estimated that around two thirds of the offers on darknet markets are drug-related. Drug sales on these markets, although modest when compared to the overall retail drug market, are significant and appear to be expanding (EMCDDA)
Supply-Side Drug Policy in the Presence of Substitutes
Evidence from the Introduction of Abuse-Deterrent Opioids (NBER)
How illegal drugs sustain organised crime in the EU (PDF)
Drug markets remain the largest criminal markets in the EU. More than one third of the criminal groups active in the EU are involved in the production, trafficking or distribution of various types of drugs (Europol, Belgium)
Developing drug supply monitoring in Europe: current concepts
This paper presents the EMCDDA’s current thinking on the conceptual framework for monitoring drug markets, crime and supply reduction — building on the work completed in this area and expanding to reflect the academic research underpinning this work and the developments observed
Drugs and the darknet: perspectives for enforcement, research and policy
A joint publication by the EMCDDA and Europol, presents the latest understanding of how darknet markets function, the threats they pose to health and security and how Europe can respond
Global Synthetic Drugs Assessment (PDF)
Amphetamine-type stimulants and new psychoactive substances (UNODC)
Drug-related intimidation – The Irish situation and international responses: an evidence review (PDF)
This report presents the findings of an evidence review on drug-related intimidation (DRI) requested by the Department of Health on behalf of the Local and Regional Drugs and Alcohol Task Forces (HRB)
The drugs situation in Ireland: an overview of trends from 2005 to 2015 (PDF)
This overview analyses ten years of data up to the most recent available with respect to the five European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) key indicators (prevalence of drug use, high risk drug use, treatment demand, drug-related deaths and mortality and drug-related infectious diseases) as well as drug-related crime and supply (Centre for Public Health at Liverpool John Moores University)
EMCDDA–Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide (furanylfentanyl)
The two organisations launched a data collection on this substance for the preparation of a Joint Report as stipulated by Article 5.1 of the Council Decision. The Joint Report was submitted to the Council, the Commission and the European Medicines Agency on 23 January 2017. Download
Public expenditure on supply reduction policies
This report takes a first step towards a systematic analysis, by examining a set of representative attempts to estimate public expenditure on supply reduction interventions (EMCDDA)
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 6
- Next Page »
